| Date | Time | Source | Headline | Symbol | Company |
| 02/09/2012 | 4:32PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/09/2012 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/09/2012 | 9:00AM | Marketwired | A Forward Look, the Year Ahead - Featured Research on BioMarin Pharmaceutical Inc. and Amylin Pharmaceuticals, Inc. | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/06/2012 | 4:58PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/06/2012 | 4:41PM | PR Newswire (US) | Amylin Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/06/2012 | 4:30AM | Zacks | Novo Nordisk Posts Solid 4Q - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/06/2012 | 3:30AM | Zacks | The Zacks Analyst Blog Highlights: Alkermes plc, Elan, Johnson & Johnson, Amylin Pharmaceuticals & Eli Lilly & Company - Pres.. | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/03/2012 | 5:15AM | Zacks | Revenues Skyrocket at Merged Alkermes - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/01/2012 | 11:18AM | Zacks | New Study for Alkermes' Vivitrol - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/31/2012 | 8:43AM | Dow Jones News | UPDATE: Lilly 4Q Net Drops 27% As Zyprexa Sales Drop 44% | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/31/2012 | 8:38AM | Zacks | Zyprexa Pulls Down Lilly's 4Q Sales - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/31/2012 | 4:00AM | Zacks | Company News for January 31, 2012 - Corporate Summary | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/30/2012 | 5:42PM | Dow Jones News | US Stocks Edge Lower As Europe's Debt Flashpoints Weigh | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/30/2012 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast 2011 Year-End Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/30/2012 | 9:01AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/30/2012 | 8:45AM | Zacks | Third Time Lucky for Amylin's Bydureon - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/30/2012 | 8:02AM | Dow Jones News | US Stock Futures Lower On Renewed Worries Over Greece | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/27/2012 | 5:56PM | Dow Jones News | 2nd UPDATE: FDA Approves Amylin's Bydureon Diabetes Drug After Delays | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/27/2012 | 4:46PM | Dow Jones News | UPDATE: FDA Approves Amylin's Bydureon Diabetes Drug After Delays | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/27/2012 | 4:12PM | Dow Jones News | FDA Approves Amylin's Bydureon Diabetes Drug After Delays | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/27/2012 | 3:39PM | PR Newswire (US) | FDA Approves BYDUREON™ -- The First and Only Once-Weekly Treatment for Type 2 Diabetes | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/19/2012 | 4:46PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/19/2012 | 4:45PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/12/2012 | 7:31PM | Dow Jones News | UK Body Recommends Lilly, Amylin Diabetes Drug Bydureon | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/12/2012 | 4:37PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/12/2012 | 4:37PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/12/2012 | 4:36PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/12/2012 | 4:35PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/12/2012 | 4:35PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/10/2012 | 8:36AM | Zacks | Amylin Provides Strategy Update - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |